Deficiency of Neuronal Nitric Oxide Synthase Increases Mortality and Cardiac Remodeling After Myocardial Infarction
Author(s) -
Roberto Magalhães Saraiva,
Khalid M. Minhas,
Shubha V.Y. Raju,
Lili A. Barouch,
Eleanor Pitz,
Karl H. Schuleri,
Koenraad Vandegaer,
Dechun Li,
Joshua M. Hare
Publication year - 2005
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.105.557892
Subject(s) - nos1 , medicine , endocrinology , nitric oxide , nitric oxide synthase , oxidative stress , contractility , xanthine oxidase , myocardial infarction , cardiology , chemistry , biochemistry , enzyme
Neuronal nitric oxide synthase (NOS1) plays key cardiac physiological roles, regulating excitation-contraction coupling and exerting an antioxidant effect that maintains tissue NO-redox equilibrium. After myocardial infarction (MI), NOS1 translocates from the sarcoplasmic reticulum to the cell membrane, where it inhibits beta-adrenergic contractility, an effect previously predicted to have adverse consequences. Counter to this idea, we tested the hypothesis that NOS1 has a protective effect after MI.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom